Qiagen (QGEN) EPS (Weighted Average and Diluted) (2009 - 2026)

Qiagen has disclosed EPS (Weighted Average and Diluted) across 18 years of filings, most recently posting $0.33 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.33, down 19.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.86 (down 10.14% YoY), and the FY2025 annual result was $1.94, up 424.32% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.33 for Q1 2026 at Qiagen, down from $0.49 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.83 in Q2 2024 to a low of $0.33 in Q1 2026.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.41 (2025), against an average of $0.45.
• Across the five-year window, EPS (Weighted Average and Diluted) soared 137.14% in 2024 and slumped 46.99% in 2025, its largest moves.
• Qiagen's EPS (Weighted Average and Diluted) stood at $0.39 in 2022, then gained by 7.69% to $0.42 in 2023, then slipped by 7.14% to $0.39 in 2024, then advanced by 25.64% to $0.49 in 2025, then sank by 32.65% to $0.33 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.33 (Q1 2026), $0.49 (Q4 2025), and $0.6 (Q3 2025), per Business Quant data.